American President Donald Trump has announced tariffs of up to 100% on the import of patented medicines into the US. According to a decree published by the White House on Thursday, a tariff of 15% will apply to Swiss pharmaceutical exports. Trump has decided to impose tariffs of up to 100% on patented medicines and their active ingredients, according to the US government’s announcement. According to the White House, the aim of the tariffs is to strengthen domestic production and reduce dependence on imports. “According to the Food and Drug Administration, as of 2025, approximately 53% of patented pharmaceutical products distributed domestically are produced outside the country. The degree of import reliance is significant at the API [active pharmaceutical ingredients] level with only 15% of patented APIs by volume domestically produced for the United States market,” stated the official communique published on Thursday. +Get the most important news from Switzerland in your inbox …